Date lodged: 5 December 2016
To ask the Scottish Government what action the NHS takes to ensure that the pharmaceutical companies from which it procures antibiotics do not have manufacturing practices that are considered to be contributing to the reported rise in antibiotic-resistant bacteria; whether it no longer uses any companies as a result of this and, if so, how many.
Answered by: Shona Robison 19 December 2016
The safety and efficacy of medicines in the UK is a reserved matter and is the responsibility of the Medicines and Healthcare products Regulatory Agency (MHRA). The MHRA also has responsibility for investigating any suggestions of poor manufacturing practice by pharmaceutical companies.